GRNA vs NOMA

Comparison between GreenLight Biosciences Inc (GRNA, Company) and Nomadar Corp - Class A (NOMA, Company).

GRNA vs NOMA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	GRNA(COMPANY)	NOMA(COMPANY)
Market Cap	$45M	$45M
Max Drawdown	98.70%	86.33%
Sharpe Ratio	-1.27	-1.39
5Y Beta	N/A	-0.18
Industry	N/A	Leisure
P/E Ratio	-1.59	N/A
Debt to Equity	112.33%	0.00%
Free Cash Flow Yield	N/A	-4.02%
P/S Ratio	4.39	46.55
P/B Ratio	2.07	4.85

Market Cap

Winner

GRNA

$45M

NOMA

$45M

Max Drawdown

GRNA

98.70%

Winner

NOMA

86.33%

Sharpe Ratio

Winner

GRNA

-1.27

NOMA

-1.39

5Y Beta

GRNA

N/A

NOMA

-0.18

Industry

GRNA

N/A

NOMA

Leisure

P/E Ratio

GRNA

-1.59

NOMA

N/A

Debt to Equity

GRNA

112.33%

Winner

NOMA

0.00%

Free Cash Flow Yield

GRNA

N/A

NOMA

-4.02%

P/S Ratio

Winner

GRNA

4.39

NOMA

46.55

P/B Ratio

Winner

GRNA

2.07

NOMA

4.85

GRNA vs NOMA - Historical Returns

Returns include dividend reinvestment.

Period	GRNA	NOMA
1 month	+0.84%	-5.12%
3 months	+42.28%	-25.80%
6 months	-59.61%	-27.92%
1 year	-92.34%	N/A
Max(CAGR)	-89.56%	-92.68%

Winner

GRNA

+0.84%

NOMA

-5.12%

Winner

GRNA

+42.28%

NOMA

-25.80%

GRNA

-59.61%

Winner

NOMA

-27.92%

GRNA

-92.34%

NOMA

N/A

Max(CAGR)

Winner

GRNA

-89.56%

NOMA

-92.68%

GRNA vs NOMA - Annual Returns (2022 - 2026)

Returns include dividend reinvestment.

Year	GRNA	NOMA
2026	N/A	-28.25%
2025	N/A	-78.67%
2023	-73.96%	N/A
2022	-87.44%	N/A

GRNA vs NOMA Drawdown Comparison

The maximum drawdown for GRNA was -98.70%, occurring on May 24, 2023. This drawdown has not yet recovered.

The maximum drawdown for NOMA was -86.33%, occurring on Jul 15, 2026. This drawdown has not yet recovered.

The current GRNA drawdown is -97.79%. The current NOMA drawdown is -85.00%.

Rank	GRNA	NOMA
#1	-98.70% Mar 21, 2022 - May 24, 2023	-86.33% Oct 31, 2025 - Jul 15, 2026
#2	-47.65% Feb 3, 2022 - Mar 10, 2022	N/A
#3	-11.72% Mar 11, 2022 - Mar 15, 2022	N/A
#4	-0.30% Mar 15, 2022 - Mar 17, 2022	N/A